Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN116462619B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel copper-catalyzed method avoids toxic CO and precious metals. Offers high yield and scalable production for reliable pharmaceutical intermediate supply chains.